Can We See the Failure Coming? | AI Learning Guide

Notice what this conclusion does not claim. It does not say we can stop drugs from failing, because we cannot. It says the useful target is timing. If a doomed candidate can be identified while it is still cheap to abandon, before patients are exposed, then the same failure costs far less. And be careful about what an early warning would actually be. It would be a risk estimate, not a verdict. A high estimate would not prove failure, and a low one would not prove success. It would only tell a team how much confidence to place in a candidate as it decides what to pursue next.

0:00 / 0:00

Auto-play

The goal is not to eliminate failure, which is impossible, but to detect it earlier, while it is still cheap and before patients are exposed.

What an early warning would look like

A useful early signal would take the information already available about a candidate, such as its chemical structure, laboratory measurements, and how similar compounds behaved in the past, and produce a risk estimate before human trials. It would inform a decision rather than make it. A high risk estimate would not prove a drug will fail, and a low one would not prove it will succeed; both would simply shift how much confidence a team places in a candidate as it decides what to pursue next.